Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System

Dorothy Rosenthal, Deborah Acosta, Ruth K. Peters

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To investigate the efficacy of the PAPNET Testing System and its ability to detect significant areas on clinically important false negative gynecologic smears. STUDY DESIGN: Sixty-two gynecologic smears that had been obtained from women studied in a previous case-control investigation, completed in 1987, and had originally been interpreted as negative were re screened by two independent, blind cytotechnologist- cytopathologist teams. Twenty-nine of these 'negative' smears were from 19 women who had been subsequently diagnosed with invasive squamous cell carcinoma and had self-reported a history of only negative gynecologic smears. Thirty-three smears were from 33 control women who did not develop cervical cancer. One team, at the University of Southern California (USC), manually rescreened the smears as part of the original study. The other team, at the University of California at Los Angeles (UCLA), recently used the PAPNET Testing System to rescreen the same smears. This computer-assisted system utilizes neural network technology to recognize and select potentially abnormal cell scenes on a conventionally prepared gynecologic smear. The PAPNET selected scenes are displayed for review by trained cytologists, who ultimately diagnose the smear. RESULTS: Manual reevaluation of the smears by the USC team in 1987 resulted in the reclassification of 9 of the 29 case smears (31%) and 2 of 33 control smears (6%) as class II to V (atypical squamous cells of undetermined significance to invasive carcinoma). Using the PAPNET System to scan and review the same smears, the cytotechnologist at UCLA referred 24 case smears to the cytopathologist, who ultimately reclassified 12 of the 29 case smears (41%) and 5 of the 33 control smears (15%) as abnormal. CONCLUSION: This study supports the rise of the PAPNET System as an effective, routine rescreener for the detection of clinically significant false negative gynecologic smears.

Original languageEnglish (US)
Pages (from-to)120-126
Number of pages7
JournalActa Cytologica
Volume40
Issue number1
StatePublished - 1996

Fingerprint

Vaginal Smears
Los Angeles
Computer Systems
Uterine Cervical Neoplasms
Squamous Cell Carcinoma
Technology
Carcinoma

Keywords

  • cervical smears
  • image analysis, computer-assisted
  • laboratory diagnosis
  • mass screening

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System. / Rosenthal, Dorothy; Acosta, Deborah; Peters, Ruth K.

In: Acta Cytologica, Vol. 40, No. 1, 1996, p. 120-126.

Research output: Contribution to journalArticle

@article{9d1d80eaf22c404c8b5adc2bb43f143c,
title = "Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System",
abstract = "OBJECTIVE: To investigate the efficacy of the PAPNET Testing System and its ability to detect significant areas on clinically important false negative gynecologic smears. STUDY DESIGN: Sixty-two gynecologic smears that had been obtained from women studied in a previous case-control investigation, completed in 1987, and had originally been interpreted as negative were re screened by two independent, blind cytotechnologist- cytopathologist teams. Twenty-nine of these 'negative' smears were from 19 women who had been subsequently diagnosed with invasive squamous cell carcinoma and had self-reported a history of only negative gynecologic smears. Thirty-three smears were from 33 control women who did not develop cervical cancer. One team, at the University of Southern California (USC), manually rescreened the smears as part of the original study. The other team, at the University of California at Los Angeles (UCLA), recently used the PAPNET Testing System to rescreen the same smears. This computer-assisted system utilizes neural network technology to recognize and select potentially abnormal cell scenes on a conventionally prepared gynecologic smear. The PAPNET selected scenes are displayed for review by trained cytologists, who ultimately diagnose the smear. RESULTS: Manual reevaluation of the smears by the USC team in 1987 resulted in the reclassification of 9 of the 29 case smears (31{\%}) and 2 of 33 control smears (6{\%}) as class II to V (atypical squamous cells of undetermined significance to invasive carcinoma). Using the PAPNET System to scan and review the same smears, the cytotechnologist at UCLA referred 24 case smears to the cytopathologist, who ultimately reclassified 12 of the 29 case smears (41{\%}) and 5 of the 33 control smears (15{\%}) as abnormal. CONCLUSION: This study supports the rise of the PAPNET System as an effective, routine rescreener for the detection of clinically significant false negative gynecologic smears.",
keywords = "cervical smears, image analysis, computer-assisted, laboratory diagnosis, mass screening",
author = "Dorothy Rosenthal and Deborah Acosta and Peters, {Ruth K.}",
year = "1996",
language = "English (US)",
volume = "40",
pages = "120--126",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System

AU - Rosenthal, Dorothy

AU - Acosta, Deborah

AU - Peters, Ruth K.

PY - 1996

Y1 - 1996

N2 - OBJECTIVE: To investigate the efficacy of the PAPNET Testing System and its ability to detect significant areas on clinically important false negative gynecologic smears. STUDY DESIGN: Sixty-two gynecologic smears that had been obtained from women studied in a previous case-control investigation, completed in 1987, and had originally been interpreted as negative were re screened by two independent, blind cytotechnologist- cytopathologist teams. Twenty-nine of these 'negative' smears were from 19 women who had been subsequently diagnosed with invasive squamous cell carcinoma and had self-reported a history of only negative gynecologic smears. Thirty-three smears were from 33 control women who did not develop cervical cancer. One team, at the University of Southern California (USC), manually rescreened the smears as part of the original study. The other team, at the University of California at Los Angeles (UCLA), recently used the PAPNET Testing System to rescreen the same smears. This computer-assisted system utilizes neural network technology to recognize and select potentially abnormal cell scenes on a conventionally prepared gynecologic smear. The PAPNET selected scenes are displayed for review by trained cytologists, who ultimately diagnose the smear. RESULTS: Manual reevaluation of the smears by the USC team in 1987 resulted in the reclassification of 9 of the 29 case smears (31%) and 2 of 33 control smears (6%) as class II to V (atypical squamous cells of undetermined significance to invasive carcinoma). Using the PAPNET System to scan and review the same smears, the cytotechnologist at UCLA referred 24 case smears to the cytopathologist, who ultimately reclassified 12 of the 29 case smears (41%) and 5 of the 33 control smears (15%) as abnormal. CONCLUSION: This study supports the rise of the PAPNET System as an effective, routine rescreener for the detection of clinically significant false negative gynecologic smears.

AB - OBJECTIVE: To investigate the efficacy of the PAPNET Testing System and its ability to detect significant areas on clinically important false negative gynecologic smears. STUDY DESIGN: Sixty-two gynecologic smears that had been obtained from women studied in a previous case-control investigation, completed in 1987, and had originally been interpreted as negative were re screened by two independent, blind cytotechnologist- cytopathologist teams. Twenty-nine of these 'negative' smears were from 19 women who had been subsequently diagnosed with invasive squamous cell carcinoma and had self-reported a history of only negative gynecologic smears. Thirty-three smears were from 33 control women who did not develop cervical cancer. One team, at the University of Southern California (USC), manually rescreened the smears as part of the original study. The other team, at the University of California at Los Angeles (UCLA), recently used the PAPNET Testing System to rescreen the same smears. This computer-assisted system utilizes neural network technology to recognize and select potentially abnormal cell scenes on a conventionally prepared gynecologic smear. The PAPNET selected scenes are displayed for review by trained cytologists, who ultimately diagnose the smear. RESULTS: Manual reevaluation of the smears by the USC team in 1987 resulted in the reclassification of 9 of the 29 case smears (31%) and 2 of 33 control smears (6%) as class II to V (atypical squamous cells of undetermined significance to invasive carcinoma). Using the PAPNET System to scan and review the same smears, the cytotechnologist at UCLA referred 24 case smears to the cytopathologist, who ultimately reclassified 12 of the 29 case smears (41%) and 5 of the 33 control smears (15%) as abnormal. CONCLUSION: This study supports the rise of the PAPNET System as an effective, routine rescreener for the detection of clinically significant false negative gynecologic smears.

KW - cervical smears

KW - image analysis, computer-assisted

KW - laboratory diagnosis

KW - mass screening

UR - http://www.scopus.com/inward/record.url?scp=0030071468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030071468&partnerID=8YFLogxK

M3 - Article

C2 - 8604564

AN - SCOPUS:0030071468

VL - 40

SP - 120

EP - 126

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 1

ER -